Key result
Prednisolone halts recurrent stent thrombosis over 18 months in a complex prothrombotic metal allergy case.
Case Report (n=1)
No
Prednisolone may warrant trial in refractory stent thrombosis with metal allergy; single-case data leave efficacy unproven.
A 43-year-old woman recipient of a bare metal coronary stent during an acute anterior myocardial infarction was repeatedly hospitalized with recurrent stent thrombosis (ST) over the following 3 years. Emergent coronary angiography showed a thrombus in the in-stent segment of the proximal left anterior descending artery. We repeatedly aspirated the thrombus, which immediately reformed multiple times. The discontinuation of heparin and administration of thrombolytics and argatroban, followed by repeated balloon dilatations, ended the formation of new thrombi. The patient was found to be allergic to nickel, protein S deficient and carrier of heparin-induced thrombocytopenia antibody. We discuss this case in the context of a) literature pertaining to acute coronary syndromes in the young, and b) the detailed investigations needed to identify thrombotic risk factors. Steroids may be effective to prevent recurrent ST caused by stent allergy.
No takes yet. Share an insight, caveat, or question.
Konishi et al. (2015) conducted a case report in Recurrent stent thrombosis (n=1). Prednisolone was evaluated on Recurrence of stent thrombosis. In a 43-year-old woman with recurrent stent thrombosis caused by metal allergy, protein S deficiency, and heparin-induced thrombocytopenia, prednisolone therapy prevented further thrombotic events over an 18-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: